Proceedings of the 2023 Viral Clearance Symposium, Session 5: Viral Clearance Strategy and Process Understanding

References

1. 1.↵
   1. Ajayi O. O.,
   2. Johnson S. A.,
   3. Faison T.,
   4. Azer N.,
   5. Cullinan J. L.,
   6. Dement-Brown J.,
   7. Lute S. C.

   An Updated Analysis of Viral Clearance Unit Operations for Biotechnology Manufacturing. Curr. Res. Biotechnol. 2022, 4, 190–202.

   OpenUrl
2. 2.↵
   1. Johnson S. A.,
   2. Chen S.,
   3. Bolton G.,
   4. Chen Q.,
   5. Lute S.,
   6. Fisher J.,
   7. Brorson K.

   Virus Filtration: A Review of Current and Future Practices in Bioprocessing. Biotechnol. Bioeng. 2022, 119 (3), 743–761.

   OpenUrl
3. 3.↵
   1. Stanley B.,
   2. Holmes V.,
   3. Manzari R.,
   4. Romanowski C.,
   5. Tessarz A.,
   6. Ruppach H.,
   7. Schreffler J.

   Twenty plus Years of Data Demonstrating Virus Filtration as an Effective and Robust Step for Large Virus Removal. PDA J. Pharm. Sci. Technol. 2022, 76 (1), 1–8.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Arentsen A. C.,
   2. Kamstrup S.

   A Challenge in Viral Clearance Determination: Estimation of Fifty-Percent Tissue Culture Infective Dose (TCID₅₀) for Low Virus Concentrations. BioProcess Int. 2020, 18 (4), 40–41.

   OpenUrl
5. 5.↵
   1. Orchard J. D.,
   2. Cetlin D.,
   3. Pallansch M.,
   4. Barlow R.,
   5. Borman J.,
   6. Dhar A.,
   7. Pallansch L.,
   8. Dickson M.

   Using a Noninfectious MVM Surrogate for Assessing Viral Clearance during Downstream Process Development. Biotechnol. Prog. 2019, 36 (1), e2921.

   OpenUrl
6. 6.↵
   1. Zhang M.,
   2. Miesegaes G. R.,
   3. Lee M.,
   4. Coleman D.,
   5. Yang B.,
   6. Trexler-Schmidt M.,
   7. Norling L.,
   8. Lester P.,
   9. Brorson K. A.,
   10. Chen Q.

   Quality by Design Approach for Viral Clearance by Protein a Chromatography. Biotechnol. Bioeng. 2014, 111 (1), 95–103.

   OpenUrl
7. 7.↵
   1. Feroz H.,
   2. Cetnar D.,
   3. Hewlett R.,
   4. Sharma S.,
   5. Holstein M.,
   6. Ghose S.,
   7. Li Z. J.

   Surrogate Model to Screen for Inactivation-Based Clearance of Enveloped Viruses during Biotherapeutics Process Development. Biotechnol. J. 2021, 16 (12), e2100176.

   OpenUrl
8. 8.↵
   1. Kayukawa T.,
   2. Yanagibashi A.,
   3. Hongo-Hirasaki T.,
   4. Yanagida K.

   Particle-Based Analysis Elucidates the Real Retention Capacities of Virus Filters and Enables Optimal Virus Clearance Study Design with Evaluation Systems of Diverse Virological Characteristics. Biotechnol. Prog. 2022, 38 (2), e3237.

   OpenUrl
9. 9.↵
   1. Kærsgaard P.,
   2. Kamstrup S.,
   3. Halkjær E.

   Virus Segregation during Purification Processes: Calculation of Critical Potential Carryover of Viruses. BioProcess Int. 2018, 16 (9), 46–49.

   OpenUrl